Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
DNLI | Denali Therapeutics Inc. | President and CEO, Director | $50 M | -$776 K | -1.53% | Mar 29, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|